Skip to main content

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1632972 PLYMOUTH, MN

Position in ESPR

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$38,934
+$38,934 QoQ
Shares Held
12,321
-48.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 40 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Derivatives in ESPR

reported options exposure · as of Mar 31, 2024
CallValue
$0
CallShares
10,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $45,863,285 across 32 Drug Manufacturers - Specialty & Generic names. ESPR ranks #28 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,934 12,321
2026-03-31 23,968
2025-12-31 28,338
2025-09-30 23,916
2025-06-30 15,522
2024-09-30 23,661
2024-06-30 18,821
2024-03-31 10,000
2024-03-31 11,721